LifeSci Acquisition Corp.
Status: Closed Deal
U=S+W
W=S/2@11.5
| IPO Proceeds, $M | $65.64M |
|---|---|
| IPO Date | Mar 6, 2020 |
| CEO | Andrew McDonald, Ph.D. |
| Left Lead | Chardan |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | US/Canada |
| Target Company | Vincera Pharma |
| Deal Announced | Sep 29, 2020 |
| Deal Size, $M | $77.05M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Dec 22, 2020 |
| Amendment Vote | TBD |
| Closing Date | Dec 23, 2020 |
Formerly LSAC
VINC
VINCW
| Price | $0.06 $0.00 |
|---|---|
| Last closing price | $0.10 |
| H/L, today | $0.05 / $0.06 |
| H/L, 52-week | $0.63 / $1.95 |
| Volume, today | 70,659 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.